Sales 2024 * | 43.06M 31.48M | Sales 2025 * | 58.43M 42.71M | Capitalization | 34.34M 25.1M |
---|---|---|---|---|---|
Net income 2024 * | -7M -5.12M | Net income 2025 * | -1M -731K | EV / Sales 2024 * | 0.8 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.59 x |
P/E ratio 2024 * |
-5.67
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.53% |
Latest transcript on Medipharm Labs Corp
Managers | Title | Age | Since |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 22-04-19 |
Greg Hunter
DFI | Director of Finance/CFO | - | 21-02-07 |
Keith Strachan
PSD | President | - | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bumby
BRD | Director/Board Member | 60 | 23-03-31 |
David Pidduck
CEO | Chief Executive Officer | - | 22-04-19 |
Shelley Martin
BRD | Director/Board Member | - | 20-06-21 |
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.18B | |
+3.98% | 3.16B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |